Allmed Medical(SZ:002950) Sou Hu Cai Jing·2025-07-30 12:21Core Viewpoint - The recent large block trades in Aomei Medical (002950) indicate significant institutional buying activity, suggesting potential long-term investment interest despite the stock's price discount compared to market value [1][2]. Group 1: Trading Activity - On July 30, Aomei Medical experienced 7 large block trades totaling 5.04 million shares, with a transaction value of 42.99 million yuan, at an average price of 8.53 yuan per share, representing an 8.38% discount to the closing price of 9.31 yuan [1]. - Institutional investors accounted for 6 of the trades, purchasing 4.64 million shares worth 39.58 million yuan, which is 92% of the total transaction value [1]. - The stock's trading volume on the same day was 55.66 million yuan, with large block trades making up 77.24% of this volume [1]. Group 2: Shareholder Activity - On July 21, shareholder Chen Haohua reduced his stake by 4.21 million shares, representing 0.67% of the total share capital, bringing his holding to 10.87% [2]. - The subsequent three days of large block trades were linked to the same brokerage firm involved in Chen's share reduction, indicating that institutions may have been the primary buyers of the sold shares [2]. Group 3: Market Context and Financial Performance - The overall market saw high activity in large block trades, with companies like China Merchants Bank and Hengli Petrochemical also reporting significant transactions [2]. - As of July 30, Aomei Medical's stock price slightly increased by 0.11% to 9.31 yuan, with a total market capitalization of 5.896 billion yuan and a price-to-earnings ratio of 17.04 [2]. - For the first quarter of 2025, Aomei Medical reported revenues of 759 million yuan and a net profit of 86.5 million yuan [2].